These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8872958)

  • 1. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
    Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
    Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
    Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
    J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
    Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
    J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of interleukin 1beta by matrix metalloproteinases.
    Ito A; Mukaiyama A; Itoh Y; Nagase H; Thogersen IB; Enghild JJ; Sasaguri Y; Mori Y
    J Biol Chem; 1996 Jun; 271(25):14657-60. PubMed ID: 8663297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and their inhibitors in gastric cancer.
    Murray GI; Duncan ME; Arbuckle E; Melvin WT; Fothergill JE
    Gut; 1998 Dec; 43(6):791-7. PubMed ID: 9824606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of gelatinases/type IV collagenases in jaw cysts.
    Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Hietanen J; Sorsa T
    J Oral Pathol Med; 1995 Feb; 24(2):78-84. PubMed ID: 7745546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio.
    Kenney MC; Chwa M; Opbroek AJ; Brown DJ
    Cornea; 1994 Mar; 13(2):114-24. PubMed ID: 8156782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
    Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
    Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
    Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
    Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat.
    Schaefer L; Han X; Gretz N; Häfner C; Meier K; Matzkies F; Schaefer RM
    Kidney Int; 1996 Jan; 49(1):75-81. PubMed ID: 8770951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells.
    Frölichsthal-Schoeller P; Vescovi AL; Krekoski CA; Murphy G; Edwards DR; Forsyth P
    Neuroreport; 1999 Feb; 10(2):345-51. PubMed ID: 10203333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
    Reynolds JJ
    Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and their inhibitors.
    Kugler A
    Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
    Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
    Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
    J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.